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Background: Tonsillectomy is a commonly performed surgical procedure that involves removal of the palatine tonsils. The
purpose of this study is to examine the association between previous tonsillectomy and odds of oropharyngeal squamous cell
carcinoma (OPSCC) in a large population-based case–control study. We hypothesise that previous tonsillectomy is associated with
a decreased odds of tonsil cancer with no impact on the odds of developing base of tongue (BOT) cancer.
Methods: This was a population-based, frequency-matched case–control study with multinomial logistic regression, including
1378 controls, 108 BOT cancer cases, and 198 tonsil cancer cases. Demographic and risk factor data were collected using a
structured questionnaire during an in-home visit conducted by trained nurse-interviewers. The human papillomavirus (HPV)
tumour status was determined through Luminex-based multiplex PCR and p16 status by immunohistochemistry.
Results: Previous tonsillectomy was associated with a nearly two-fold increased odds of BOT cancer (OR¼ 1.95, 95% CI 1.25–3.06,
P¼ 0.003) and a large decrease in the odds of tonsil cancer (OR¼ 0.22, 95% CI 0.13–0.36, Po0.001). When HPV status was
considered, tonsillectomy was associated with a decreased odds of HPV-positive tonsil cancer (OR¼ 0.17, 95% CI 0.08–0.34,
Po0.001) and an increased risk of HPV-positive BOT cancer (OR¼ 2.46, 95% CI 1.22–4.95, P¼ 0.012). When p16 status was
considered, tonsillectomy was associated with an increased odds of p16-positive BOT cancer (OR¼ 2.24, 95% CI 1.16–4.35,
P¼ 0.017) and a decreased odds of p16-positive tonsil cancer (OR¼ 0.14, 95% CI 0.07–0.31, Po0.001).
Conclusions: Previous tonsillectomy modifies the odds of both tonsil and BOT cancer, with decreased odds of tonsil cancer and
increased odds of BOT cancer. A history of previous tonsillectomy may play a role in OPSCC risk stratification when considered
along with other covariates such as sexual history, smoking status, and age.
Oropharyngeal squamous cell carcinoma (OPSCC) is an increas-
ingly common cancer of the upper aerodigestive tract, and includes
cancers arising from the tonsils, base of tongue (BOT), soft palate,
and lateral and posterior pharyngeal walls. Although traditionally
associated with heavy tobacco and alcohol consumption, it is
estimated thatB60–70% of incident OPSCC cases are attributable
to human papillomavirus (HPV) (D’Souza et al, 2007; Ang et al,
2010; Chaturvedi et al, 2011). A rise in HPV-positive OPSCC has
occurred since the 1980s in the United States that has been
attributed to changing sexual practices beginning in the 1960s
(Ernster et al, 2007; Chaturvedi et al, 2013). The HPV epidemic has
changed the demographic characteristics of OPSCC patients
considerably. Patients with HPV-positive OPSCC are generally
younger than those with HPV-negative OPSCC and are often
never smokers. An association with increased number of sexual
partners and earlier sexual debut has also been demonstrated
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(D’Souza et al, 2009; Heck et al, 2010). The HPV-positive OPSCC
is an increasingly significant public health problem; it is projected
that by 2020 HPV-positive OPSCC will overtake cervical cancer as
the most common HPV-related malignancy in the United States
(Chaturvedi et al, 2011).
Tonsillectomy is a commonly performed surgical procedure that
involves removal of the palatine tonsils, most often in children for
hypertrophic tonsils, chronic infection, or obstructive sleep apnoea
(Derkay, 1993). The rates of tonsillectomy in the United States
have changed significantly over the past several decades. Rosenfeld
and Green (1990) and others (Derkay, 1993; Erickson et al, 2009)
demonstrated a sharp decline in tonsillectomy rates beginning in
the late 1970s. It is well established that an increase in HPV-related
OPSCC began to increase in the 1990s (Chaturvedi et al, 2008,
2011, 2013). The association between tonsillectomy and risk of
OPSCC has not been extensively investigated. A recent study of the
Danish Cancer Registry suggests a reduction in risk of tonsil cancer
in patients with a previous history of tonsillectomy (Fakhry et al,
2015). The purpose of this study is to examine the association
between previous tonsillectomy and risk of OPSCC using a
large North Carolina population-based head and neck cancer
case–control study. We hypothesise that previous tonsillectomy is
associated with a decreased risk of tonsil cancer with no impact on
the risk of BOT cancer.
MATERIALS AND METHODS
Study population. The Carolina Head and Neck Cancer Study
(CHANCE) is a population-based case–control study of squamous
cell carcinoma of the head and neck (Divaris et al, 2010). Case
ascertainment utilised rapid ascertainment of newly diagnosed
cancer cases through the North Carolina Central Cancer Registry.
Cases were diagnosed with primary squamous cell carcinoma of
the oral cavity, pharynx, and larynx between 1 January 2002 and 28
February 2006, were aged 20 to 80 years at diagnosis, and resided
in a 46-county region in central North Carolina. Benign tumours,
carcinomas in situ, papillary carcinomas, and adenocarcinomas
were excluded. Controls were identified through the North
Carolina Department of Motor Vehicle records and were frequency
matched with cases on age, race, and sex.
The Carolina Head and Neck Cancer Study enrolled 1368 total
cases; however, as we are only interested in OPSCC, we restricted
the tumour site to only the oropharynx (N¼ 372). Race other than
European American and African American were excluded from the
analysis because of sparse numbers (N¼ 11). As we are interested
specifically in the OPSCC subsites, cases were classified into two
categories: (1) BOT: C01.9 and C02.4 and (2) tonsil: C09.0, C09.1,
C09.8, and C09.9. We excluded OPSCC of the vallecular
(C10.0; N¼ 10), soft palate (C05.1, C05.2; N¼ 23), and unspecified
subsites (C10.8 and C10.9; N¼ 23) because of small sample size.
The HPV typing and p16 immunohistochemistry was performed
on all cases of oropharyngeal tumours for which tumour blocks
were available (N¼ 213). All European-American and African-
American controls were included in the analysis (N¼ 1378). This
study was approved by the institutional review board at the
University of North Carolina at Chapel Hill.
Questionnaire and clinical assessment. Demographic, lifestyle,
oral health, diet, and other risk factor information were collected
using a structured questionnaire during an in-home visit
conducted by trained nurse-interviewers. The median time
between diagnosis and in-home interview was 4 months (inter-
quartile range: 3–6 months). Two questions addressed a history of
previous tonsillectomy, including, ‘Were your tonsils removed?’
and ‘How old were you when tonsils removed?’ For subjects who
were unable to recall the exact age of tonsillectomy, the subject was
able to answer child, teenager, or adult. Age at tonsillectomy was
defined as before 13 years of age (child) and after 13 years of age
(teenager and adult). The CHANCE questionnaire focussed on
lifestyle and medical and family history risk factors. Interviewers
did not collect information on tonsillectomy performed as part of
the diagnostic workup or OPSCC therapy. Confounders to be
adjusted for in statistical models were selected a priori based on
their potential association with risk of OPSCC and tonsillectomy.
Confounders obtained from the questionnaire included: age race,
sex, smoking (o10 pack-years and X10 pack-years), insurance
status (private, Medicare/Medicaid, none, and other), education
(some high school, completed high school, some college and
above), alcohol (1 drink or less per week/41 drink a week), and
number of sexual partners (0–1, 2–5, 6–14, and 14þ ).
p16 immunohistochemistry and HPV typing. Immunohisto-
chemistry (IHC) for p16 was performed according to the protocol
provided with the CINtec Histology p16INK4a Kit (Ref 9511, mtm
laboratories, Heidelberg, Germany) for the qualitative detection of
the p16 antigen on slides prepared from formalin-fixed, paraffin-
embedded biopsies. The p16 IHC scoring method used in this
study was developed based on the methodology by Koo et al
(2009), where expression was scored based on the percentage
(0%¼ 0, 1–10%¼ 1, 11–50%¼ 2, 51–80%¼ 3, and 81–100%¼ 4)
and intensity (none¼ 0, weak¼ 1, moderate¼ 2, and strong¼ 3)
of nuclear or cytoplasmic staining, and a combined score of X4
was considered positive for p16 overexpression. This algorithm has
been previously published in a study from the International
Agency for Research on Cancer (IARC) (Anantharaman et al,
2013), and has been compared with other p16 scoring methods
with similar results (Weinberger et al, 2006; Smeets et al, 2007;
Singhi and Westra, 2010). The HPV typing was determined
through DNA extraction and genotyping by Luminex-based
multiplex PCR (TS-E7-MPG, IARC, Lyon, France) (Gheit et al,
2006; Schmitt et al, 2006, 2010). Tumours were classified as HPV-
positive if they were positive for HPV16 or HPV18.
Statistical analysis. Differences in descriptive statistics by OPSCC
subsite were estimated using the w2 test and Fisher’s exact test
when cells were sparse. Unconditional logistic regression was used
to calculate odds ratio (OR) adjusted with the confounders and
matching factors: age, race, and gender. Subsite-specific adjusted
ORs were calculated with unconditional multinomial logistic
regression. To further explore the role of HPV, conditional logistic
regression was used to calculate HPV/p16 status and subsite
stratified ORs based on the matching factors, including age
(defined in 7 categories), race (White/Black), and sex. All statistical
analyses were implemented using SAS 9.3 (SAS Institute, Cary,
NC, USA).
RESULTS
The study population comprised 1378 controls and 361 OPSCC
cases, including 108 BOT and 198 tonsil cancer cases. Table 1
shows the demographic, risk factor, and tumour characteristics of
the controls and cases by subsite. Cases and controls differed with
respect to sex, age, tobacco pack-years, education level, insurance
status, age at tonsillectomy, and rates of previous tonsillectomy
(40% vs 26.3% in controls and cases, respectively, Po0.001).
Among study subjects with a history of tonsillectomy, 2 (2.5%)
cases and 6 (1.1%) controls underwent the procedure within 10
years of enrolment in the study. No significant differences were
noted between BOT and tonsil cancer cases with respect to age, sex,
race, education and insurance status, p16 tumour status, and HPV
tumour status. A history of previous tonsillectomy differed
significant between tonsil (11.3%) and BOT (53.3%) cancer cases
(Po0.0001). The BOT cancer cases with a history of tonsillectomy
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were significantly more likely to have undergone the procedure in
childhood (92.9% among BOT cases and 68.2% among tonsil
cancer cases, Po0.001).
Table 2 presents the results of the logistic regression model for
selected factors and the odds of OPSCC by subsite. A greater
number of sexual partners and 410 pack-year tobacco history
were associated with an increased odds of all OPSCC, tonsil, and
BOT cancers compared with controls. When all OPSCC cases were
evaluated, there was a significantly decreased odds of cancer
associated with previous tonsillectomy (OR¼ 0.63, 95% confidence
interval (CI) 0.47–0.85, P¼ 0.003). When OPSCC subsite was
considered, previous tonsillectomy was associated with a nearly
two-fold increased odds of BOT cancer (OR¼ 1.95, 95%
CI 1.25–3.06, P¼ 0.003) and a large decrease in the odds of tonsil
cancer (OR¼ 0.22, 95% CI 0.13–0.36, Po0.001). We found
tonsillectomy not associated with sites of head and neck cancer
not commonly associated with HPV (Supplementary Table S1).
We then considered whether age at tonsillectomy affected the risk
of OPSCC by subsite (Table 3). Childhood tonsillectomy (ageo13
years) was strongly associated with increased odds of BOT cancer
(adjusted OR¼ 2.46, 95% CI 1.55–3.92, Po0.001), and no
association was noted with tonsillectomy after age 13 years
(OR¼ 0.33, 95% CI 0.08–1.42, P¼ 0.138). Tonsillectomy before
age 13 years (OR¼ 0.19, 95% CI 0.10–0.33, Po0.001) and after age
13 years (OR¼ 0.32, 95% CI 0.14–01.00, P¼ 0.017) was associated
with a significantly decreased odds of tonsil cancer.
In an exploratory analysis including cases with available tumour
tissue, we then examined the odds of tonsil and BOT cancer by









N (%) N (%) P-value N (%) N (%) P-value
Tonsillectomy
No 815 (60%) 260 (73.7%) o0.001 49 (46.7%) 173 (88.7%) o0.001
Yes 544 (40%) 93 (26.3%) 56 (53.3%) 22 (11.3%)
Missing 19 8 3 3
Race
White 1114 (80.8%) 277 (76.7%) 0.082 88 (81.5%) 153 (77.3%) 0.390
Black 264 (19.2%) 84 (23.3%) 20 (18.5%) 45 (22.7%)
Education
Some High School 217 (15.7%) 98 (27.1%) o0.001 22 (20.4%) 55 (27.8%) 0.192
Completed High School 332 (24.1%) 97 (26.9%) 28 (25.9%) 57 (28.8%)
Some College and above 829 (60.2%) 166 (46%) 58 (53.7%) 86 (43.4%)
Tobacco pack-years
p10 Pack-years 765 (55.8%) 112 (31.4%) o0.001 36 (33.3%) 63 (32%) 0.809
410 Pack-years 606 (44.2%) 245 (68.6%) 72 (66.7%) 134 (68%)
Missing 7 4 1
Sex
Male 960 (69.7%) 299 (82.8%) o0.001 95 (88%) 165 (83.3%) 0.279
Female 418 (30.3%) 62 (17.2%) 13 (12%) 33 (16.7%)
Insurance
Private 556 (40.4%) 181 (50.3%) o0.001 59 (54.6%) 104 (52.5%) 0.980
Medicaid/Medicare 437 (31.7%) 93 (25.8%) 24 (22.2%) 44 (22.2%)
None 76 (5.5%) 40 (11.1%) 11 (10.2%) 22 (11.1%)
Other 308 (22.4%) 46 (12.8%) 14 (13%) 28 (14.1%)
Missing 1 1
Tumour p16 status
Positive – 84 (34.0%) – 46 (65.7%) 99 (69.2%) 0.6051
Negative – 163 (66.0%) 24 (34.3%) 44 (30.8%)
Missing 1378 125 38 55
Tumour human papillomavirus (HPV) status
Positive – 168 (67.7%) – 43 (60.6%) 104 (72.7%) 0.0708
Negative – 80 (32.3%) 28 (39.4%) 39 (27.3%)
Missing 1378 124 37 55
Age
o50 Years 156 (11.3%) 86 (23.8%) o0.001 18 (16.7%) 52 (26.3%) 0.397
50–54 Years 161 (11.7%) 84 (23.3%) 29 (26.9%) 50 (25.3%)
55–59 Years 207 (15%) 69 (19.1%) 21 (19.4%) 42 (21.2%)
60–64 Years 205 (14.9%) 53 (14.7%) 17 (15.7%) 22 (11.1%)
65–69 Years 247 (17.9%) 35 (9.7%) 10 (9.3%) 18 (9.1%)
70–74 Years 231 (16.8%) 25 (6.9%) 10 (9.3%) 10 (5.1%)
475 Years 171 (12.4%) 9 (2.5%) 3 (2.8%) 4 (2%)
Age at tonsillectomy
Child 417 (77.1%) 76 (82.6%) o0.001 52 (92.9%) 15 (68.2%) o0.001
Teenager 37 (6.8%) 5 (5.4%) 1 (1.8%) 3 (13.6%)
Adult 87 (16.1%) 11 (12.0%) 3 (5.4%) 4 (18.2%)
No tonsillectomy 815 260 49 173
Missing 22 9 3 3
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HPV and by p16 status (Table 4). Tonsillectomy was associated
with a decreased odds of HPV-positive tonsil cancer (OR¼ 0.17,
95% CI 0.08–0.34, Po0.001) and a decreased but imprecise odds of
HPV-negative tonsil cancer (OR¼ 0.66, 95% CI 0.24–1.81,
P¼ 0.415). Conversely, tonsillectomy was associated with an
increased odds of HPV-positive BOT cancer (OR¼ 2.46, 95% CI
Table 2. Adjusted odds ratio for all oropharyngeal cancer cases and by subsite compared with controlsa
Oropharyngeal cancer Base of tongue cancer Tonsil cancer
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Tonsillectomy
No Ref – Ref – Ref –
Yes 0.63 (0.47–0.85) 0.003 1.95 (1.25–3.06) 0.003 0.22 (0.13–0.36) o0.001
Number of sexual partners
0–1 Ref – Ref – Ref –
2–5 2.44 (1.40–4.27) 0.002 2.1 (0.84–5.21) 0.110 3.44 (1.5–7.91) 0.004
6–14 3.81 (2.19–6.60) o0.001 3.42 (1.42–8.27) 0.006 5.69 (2.49–13) o0.001
14þ 4.65 (2.65–8.18) o0.001 3.75 (1.52–9.21) 0.004 7.73 (3.33–17.96) o0.001
Education
Some High School Ref – Ref – Ref –
Completed High School 0.61 (0.41–0.91) –0.015 0.67 (0.34–1.32) –0.248 0.59 (0.36–0.97) –0.037
Some College and above 0.45 (0.31–0.66) o0.001 0.54 (0.29–1.03) 0.061 0.4 (0.25–0.64) o0.001
Pack-years
o10 Pack-years Ref – Ref – Ref –
X10 Pack-years 2.2 (1.62–2.97) o0.001 1.91 (1.18–3.09) 0.009 2.23 (1.5–3.32) o0.001
Insurance
Private Ref – Ref – Ref –
Medicaid/Medicare 0.84 (0.57–1.25) 0.393 0.59 (0.3–1.13) 0.113 0.78 (0.46–1.31) 0.341
None 0.92 (0.55–1.53) 0.743 0.86 (0.37–1.98) 0.717 0.93 (0.51–1.72) 0.823
Other 0.7 (0.45–1.09) 0.112 0.6 (0.3–1.19) 0.1434 0.81 (0.47–1.41) 0.464
Alcohol
p1 Drink per week Ref – Ref – Ref –
41 Drink per week 1.72 (1.16–2.56) 0.007 1.23 (0.67–2.27) 0.503 1.67 (0.98–2.84) 0.058
Abbreviations: CI¼ confidence interval; OR¼odds ratio; Ref¼ reference value.
aOdds ratios are all mutually adjusted for in addition to matching factors (age, race, and gender).
Table 3. Adjusted odds ratios for age at tonsillectomy by oropharyngeal subsite compared with controlsa
Base of tongue Tonsil
OR (95% CI) P-value OR (95% CI) P-value
Age at tonsillectomy
No tonsillectomy Ref – Ref –
o13 years 2.46 (1.55–3.92) o0.001 0.19 (0.1–0.34) o0.001
X13 years 0.33 (0.08–1.42) 0.138 0.32 (0.14–0.72) 0.006
Number of sexual partners
0–1 Ref – Ref –
2–5 2.22 (0.89–5.54) 0.087 3.46 (1.5–7.95) 0.004
6–14 3.5 (1.45–8.45) 0.005 5.71 (2.5–13.05) o0.001
14þ 3.96 (1.61–9.73) 0.003 7.8 (3.36–18.15) o0.001
Education
Some High School Ref – Ref –
Completed High School 0.66 (0.34–1.31) 0.234 0.59 (0.36–0.96) 0.034
Some College and above 0.5 (0.26–0.94) 0.031 0.4 (0.25–0.64) o0.001
Pack-years
o10 Pack-years Ref – Ref –
X10 Pack-years 1.88 (1.16–3.04) 0.011 1.66 (0.98–2.83) 0.061
Insurance
Private Ref – Ref –
Medicaid/Medicare 0.59 (0.31–1.15) 0.120 0.78 (0.47–1.32) 0.360
None 0.81 (0.35–1.87) 0.624 0.92 (0.5–1.7) 0.797
Other 0.59 (0.3–1.18) 0.138 0.81 (0.47–1.41) 0.457
Alcohol
p1 drink per week Ref – Ref –
41 drink per week 1.30 (0.7–2.39) 0.402 2.24 (1.51–3.32) o0.001
Abbreviations: CI¼ confidence interval; OR¼odds ratio; Ref¼ reference value.
aOdds ratios are all mutually adjusted for in addition to matching factors (age, race, and gender).
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1.22–4.95, P¼ 0.012) and a weak and imprecise increase in odds of
HPV-negative BOT cancer (OR¼ 1.24, 95% CI 0.46–3.31, P¼ 0.671).
Tonsillectomy was also associated with a significantly increased odds
of p16-positive BOT cancer (OR¼ 2.24, 95% CI 1.16–4.35, P¼ 0.017)
and only a weak increase in odds of p16-negative BOT cancer
(OR¼ 1.21, 95% CI 0.43–3.36, P¼ 0.716). Tonsillectomy was
associated with decreased odds of p16-positive tonsil cancer
(OR¼ 0.14, 95% CI 0.07–0.31, Po0.001). A decrease of p16-negative
tonsil cancer was also seen, but the OR had a very wide CI
(OR¼ 0.81, 95% CI 0.31–2.10, P¼ 0.670). Finally, similar results were
noted between previous tonsillectomy, HPVþ /p16þ BOT cancer
(OR¼ 2.18, 95% CI 1.1–4.4), and HPVþ /p16þ tonsil cancer
(OR¼ 0.16, 95% CI 0.08–0.37).
DISCUSSION
This population-based case–control study explores the association
between previous tonsillectomy and odds of OPSCC. We found
that previous tonsillectomy was associated with a significantly
decreased odds of OPSCC overall that was driven by a sharp and
expected decrease in tonsil cancer specifically. These data suggest
that tonsillectomy results in a reduction of oropharyngeal
lymphoid tissue susceptible to malignant transformation (Fakhry
et al, 2015). An unexpected finding from this analysis was the
positive association between odds of BOT cancer and previous
tonsillectomy. Although having a tonsillectomy is inversely
associated with odds of tonsil cancer, our data suggest that
tonsillectomy may be associated with an increased odds of BOT
cancer. One possible explanation is lingual tonsillar hypertrophy in
patients with a history of tonsillectomy, resulting in increased
lymphoid tissue in the BOT. Enlargement of the lingual tonsils has
been noted in up to one-third of paediatric patients undergoing
adenotonsillectomy (Fricke et al, 2006), and is a recognised cause
of persistent sleep apnoea and airway obstruction in this
population (Jesberg, 1956; Golding-Wood and Whittet, 1989;
Cohle et al, 1993; Jones and Cohle, 1993; Breitmeier et al, 2005;
Abdel-Aziz et al, 2011; Friedman et al, 2015). Our data suggest that
the odds of BOT cancer is strongly increased in patients
undergoing tonsillectomy as children (age o13 years) compared
with adolescents and adults (age 413 years). The difference in
odds of BOT cancer by age of tonsillectomy further supports the
possible association between lingual tonsillar hypertrophy and
increased susceptibility to BOT cancer. The most common
indication for tonsillectomy in children is obstruction secondary
to adenotonsillar hypertrophy (Smith and Pereira, 2007;
Macfarlane et al, 2008). In contrast, the most common indication
for tonsillectomy in adults is chronic or recurrent tonsillitis
(Hoddeson and Gourin, 2009).
An exploratory analysis of the association between tonsillect-
omy, tonsil, and BOT cancer, and HPV status yielded interesting
results. When both subsite and HPV status were considered, we
demonstrated that tonsillectomy was associated with a significantly
decreased odds of HPV-positive tonsil cancer and a decreased but
insignificant odds of HPV-negative tonsil cancer. The weaker
association between tonsillectomy and HPV-negative tonsil cancer
may result from susceptibility of nonlymphoid tissues of the
tonsillar region (anterior tonsillar pillars, posterior tonsillar pillars,
and tonsillar fossa) to HPV-negative, tobacco-associated cancer
even in the setting of previous tonsillectomy. Ultimately, the
decrease in odds of tonsil cancer in patients with a history of
tonsillectomy is expected and logical. The association by HPV
status should be explored further in larger studies. With respect of
HPV-positive and HPV-negative BOT cancer, our data suggest
that the association between tonsillectomy and an increased odds
of BOT cancer is strongest for HPV-positive tumours. The reason
for this difference by HPV status remains unclear and warrants
further investigation, and may reflect a relatively small sample size
of HPV-negative tumours.
Recently, the possibility of prophylactic tonsillectomy as a
method of secondary OPSCC prevention has been considered
(Chaturvedi, 2015; Fakhry et al, 2015). Although we demonstrate
a reduction in overall risk of OPSCC cancer associated with
tonsillectomy, our study was not designed to address this question.
It is important to consider that despite being a commonly
performed surgery, the morbidity of tonsillectomy is not insignif-
icant (Randall and Hoffer, 1998; Windfuhr et al, 2008, 2009).
Furthermore, as demonstrated by Fakhry et al (2015), the relative
rarity of OPSCC further precludes tonsillectomy from being an
effective method of prevention. Vaccination against high-risk HPV
types has the potential to serve as a safer and more effective
method of primary prevention of OPSCC than tonsillectomy
(D’Souza and Dempsey, 2011). Nonetheless, when considered
along with other covariates such as sexual history, smoking status,
and age, a history of tonsillectomy may play a role in risk
stratification (Chaturvedi, 2015; Fakhry et al, 2015).
This study has several limitations, many of which are inherent
to the case–control study design. The use of self-reported
tonsillectomy questionnaire data presents the possibility of recall
bias and differential misclassification by disease status. However,
recall of tonsillectomy would be very long for both the cases and
the controls and at the time of recruitment. Because most
tonsillectomies among cases and controls occurred at a very young
age, medical record abstract is not feasible. Two previous studies
have examined the accuracy of tonsillectomy recall, demonstrating
sensitivity and specificity of recall were 92.7% and 77.5%
in one study and 78.9% and 80.1% in the other, respectively
(Krall et al, 1988; Linet et al, 1989). Using the false discovery and
false omission rates from these studies, we conducted a sensitivity
Table 4. Adjusted odds ratio for tonsillectomy and oropharyngeal subsite and HPV/p16 status compared with controlsa
Base of tongue/HPVþ Base of tongue/HPV Tonsil/HPVþ Tonsil/HPV
OR (95% CI) P N (%) OR (95% CI) P N (%) OR (95% CI) P N (%) OR (95% CI) P N (%)
Tonsil removed
No Ref – 17 (65.4%) Ref – 21 (72.4%) Ref – 99 (79.2%) Ref – 32 (82.1%)
Yes 2.46 (1.22–4.95) 0.012 9 (34.6%) 1.24 (0.46–3.31) 0.671 8 (27.6%) 0.17 (0.08–0.34) o0.001 26 (20.8%) 0.66 (0.24–1.81) 0.415 7 (17.9%)
Base of tongue/p16þ Base of tongue/p16 Tonsil/p16þ Tonsil/p16
Tonsil removed
No Ref – 21 (44.7%) Ref – 16 (66.7%) Ref – 95 (92.2%) Ref – 36 (81.8%)
Yes 2.24 (1.16–4.35) 0.017 26 (55.3%) 1.21 (0.43–3.36) 0.716 8 (33.3%) 0.14 (0.07–0.31) o0.001 8 (7.8%) 0.81 (0.31–2.10) 0.67 8 (18.2%)
Abbreviations: CI¼ confidence interval; HPV¼ human papillomavirus; OR¼odds ratio; Ref¼ reference value.
aAdjusted for number of sexual partners, insurance, education, pack-years, alcohol, age, race, and gender.
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analysis (methods in Supplementary Material) and found that our
estimates for tonsillectomy and tonsil cancer are very stable to
changes in recall (Supplementary Table S2). However, for BOT
cancer as differential recall between cases and controls widens, the
estimates move closer to null and eventually crosses the null
(Supplementary Table S1). It is unlikely that recall was that
dramatically different between the cases and the controls. Another
important limitation of this study is that tumour tissue was not
available for all OPSCC samples in this cohort, limiting our
analysis including HPV to a secondary, exploratory analysis. Tonsil
cancer samples were more likely to be typed and this could
potentially lead to selection bias affecting our analysis by HPV and
p16 status. However, subjects with available HPV status and those
without were similar with respect to demographics, age, smoking
history, number of sexual partners, and stage at presentation,
suggesting that HPV status would be similar between those typed
and nontyped. Possible selection bias would not affect our overall
results with respect to risk of tonsil vs BOT cancer, or our results
incorporating age at tonsillectomy, as all cases were included in
these analyses. Furthermore, our results involving HPV and p16
typing were stratified by subsite, thus diminishing the potential
impact of any selection bias. A final limitation of this study is that
some of the comparisons were based on small numbers and ORs
were associated with wide CIs. Despite these limitations, this study
offers important insight into the association between previous
tonsillectomy and risk of OPSCC.
The major strengths of this study include a relatively large
number of diverse patients and a population-based, case–control
study design. The availability of detailed smoking, HPV tumour
status, sexual history, socioeconomic status, and other demo-
graphic covariates, as well as a frequency-matched control group,
add to the validity of our findings. Data on age of tonsillectomy
allowed us to demonstrate that the majority of cases and controls
underwent tonsillectomy as children and presumably for reasons
other than suspected oropharyngeal cancer. A very small fraction
of cases and controls underwent tonsillectomy within 10 years of
OPSCC diagnosis or enrolment in CHANCE, respectively. When a
sensitivity analysis was conducted excluding subjects with a history
of tonsillectomy within 10 years of enrolment in CHANCE, there
were no significant differences in the study findings.
In conclusion, this population-based case–control study
demonstrates that previous tonsillectomy is associated with a
decreased odds of tonsil cancer and an increased odds of BOT
cancer. Although these finding do not necessarily support the role
of tonsillectomy as primary prevention, tonsillectomy should be
considered when evaluating risk for OPSCC.
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